Skip to content
MatchScript
Menu

Head-to-head · The Match Score

ShedRx vs Eve

Both scored on the same six-factor Match Score. ShedRx wins this matchup with a 86 to 57 edge.

Higher Match Score

ShedRx

#4 · Grade B+

People who want an oral or sublingual option rather than weekly injections.

Visit ShedRx
VS

Eve

#345 · Grade C

People who want women's-health GLP-1 with compounded or brand-name access.

Visit Eve

Factor by factor

The six sub-scores behind each Match Score. The quiz reweights these to your priorities — one provider can pull ahead for you on the factors you care about.

Budget Fit
84
54
Speed to Start
84
60
Formulary Match
92
90
Support Level
86
71
Flexibility
88
41
Transparency
82
28

Price, coverage & formulary

DetailShedRxEve
Semaglutide$199/mo$195/mo (compounded)
Tirzepatide$299/mo$195/mo (compounded)
CoverageAll 50 statesCoverage not published
Brand-name accessCompounded onlyYes
Oral / sublingualYesYes
Match Score86 · B+57 · C
Winner: ShedRx

ShedRx edges out Eve, 86 to 57 on the default Match Score. A weight-focused program that also offers an oral/sublingual route for the needle-averse.

Eve is still a fair pick if its strengths line up with yours — best for: People who want women's-health GLP-1 with compounded or brand-name access.

Worth a look either way: our overall #1 pick is CoreAge Rx (Match Score 91) — nationwide access, both molecules at one flat price, easy to cancel. Or take the 6-question quiz to see your personalized match.

Assume any provider we list may compensate us, at no cost to you. It never changes the Match Score.

Full ShedRx reviewFull Eve review

More head-to-heads

Or browse alternatives to ShedRx and all comparisons.

Pricing, states and verification reflect each provider's public disclosures at last review; the Match Score and its sub-scores are our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.